Have you been diagnosed with Blood Cancer. If so, you may be able to take part in a research study looking at the safety of giving a new drug called AZD9829 to patients with Leukemia.

Can we extend your life after the diagnosis of your cancer in the stomach, esophagus, or gastroesophageal junction by adding a third chemotherapy drug to the usual combination of two chemotherapy drugs? We are doing this study because we want to find out if this approach is better or worse than the usual approach for treatment of your cancer in the stomach, esophagus, or gastroesophageal junction. The usual approach is defined as care most people get for cancer in the stomach, esophagus, or gastroesophageal junction.

Dear Colleagues and Students, We are conducting a study to understand how the quality of 2D and 3D ultrasound imaging of different organs (lungs, liver etc) can be improved. You may qualify if you 21 years and older Have no known lung and heart diseases Are not pregnant Participation involves A single laboratory visit Weighing and height measurement Being scanned with non-invasive ultrasound THERE IS NO DIRECT BENEFIT FROM PARTICIPATING IN THIS STUDY, BUT THE DATA WE COLLECT MYA HELP IMPROVE ULTRASOUND IMAGING FOR PATIENTS IN THE FUTURE For information please contact Oleksii Ostras by phone at 919-579-8328 or by email at oleksii@email.unc.edu. Pinton Laboratory, Joint Department of Biomedical Engineering (9212 Mary Ellen Jones Biulding)

Do you have intermediate risk prostate cancer and don't want to undergo surgery? You may be able to participate in a research study comparing therapy based on genetic testing.

Are you or do you plan to exclusively breastfeed your baby? We are conducting a research study to determine if eating avocados changes the nutrients in your milk and if so, how that affects your baby's recognition memory and overall development. Avocados will be provided!

Have you been diagnosed with relapsed or refractory multiple myeloma? If so you may be able to take part in a research study looking at the safety and efficacy of giving BMS-986393 to patients with multiple myeloma.

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)? If so, you may be able to take part in a research study investigating if the study drug together with standard of care drug are safe and well tolerated, and whether two drugs are effective in treating prostate cancer, in comparison with standard of care alone.

Do you have type one diabetes? Have you experienced low blood sugar? If you have T1DM, are using insulin, and have a CGM, you may be able to participate in a research study to see if an oral pill used with your current medications may help to lower the risk of hypoglycemia. Compensation provided.

Are you premenopausal and have been diagnosed with ER-positive, HER2-negative breast cancer and had surgery for your breast cancer? If so, you may be able to take part in a research study evaluating the addition of chemotherapy given after breast surgery with ovarian suppression and endocrine therapy versus ovarian suppression and endocrine therapy alone.

The survey and its findings will help us understand attitudes around cancer family history and genetic testing among Black people. This information will be used to develop an educational curriculum to strive towards health equity for Black people diagnosed with or at higher risk of cancer and get Black people the best cancer care.